Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,602 | 126 | 99.4% |
| Education | $25.53 | 1 | 0.4% |
| Entertainment | $13.54 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,688 | 17 | $0 (2023) |
| Endologix LLC | $880.72 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $426.90 | 10 | $0 (2024) |
| Medtronic Vascular, Inc. | $406.70 | 2 | $0 (2019) |
| PFIZER INC. | $359.16 | 15 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $333.68 | 17 | $0 (2023) |
| Boston Scientific Corporation | $326.64 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $242.87 | 12 | $0 (2023) |
| ShockWave Medical, Inc | $232.66 | 3 | $0 (2023) |
| ABIOMED | $202.83 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.67 | 7 | Bracco Diagnostics Inc. ($191.81) |
| 2023 | $1,779 | 28 | Abbott Laboratories ($326.45) |
| 2022 | $1,286 | 28 | Abbott Laboratories ($791.89) |
| 2021 | $1,293 | 21 | Endologix LLC ($856.85) |
| 2020 | $253.03 | 13 | Novartis Pharmaceuticals Corporation ($48.19) |
| 2019 | $851.52 | 7 | Abbott Laboratories ($415.26) |
| 2018 | $326.10 | 10 | Allergan Inc. ($146.52) |
| 2017 | $478.62 | 14 | Abbott Laboratories ($125.00) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | PROCYRION, INC. | AORTIX SYSTEM (Device) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: CARDIAC ARRHYTHMIAS AND HEART FAILURE | ||||||
| 05/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/11/2024 | Terumo Medical Corporation | GLIDESHEATH SLENDER (Device) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: LESION ACCESS | ||||||
| 04/08/2024 | Bracco Diagnostics Inc. | Lumason (Drug) | Food and Beverage | In-kind items and services | $191.81 | General |
| Category: Diagnostic Imaging | ||||||
| 03/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Not Applicable | ||||||
| 02/21/2024 | Masimo Corporation | SET and rainbow SET (Device) | Food and Beverage | Cash or cash equivalent | $35.02 | General |
| Category: Devices | ||||||
| 12/07/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Not Applicable | ||||||
| 10/20/2023 | Kiniksa Pharmaceuticals, Ltd. | Arcalyst (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Not Applicable | ||||||
| 10/18/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $31.62 | General |
| Category: Cardiovascular | ||||||
| 10/11/2023 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $65.95 | General |
| Category: Vascular | ||||||
| 10/05/2023 | Bard Peripheral Vascular, Inc. | LUTONIX Drug Coated Balloon (Device) | Food and Beverage | In-kind items and services | $140.37 | General |
| Category: Vascular/Oncology | ||||||
| 10/04/2023 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $173.92 | General |
| Category: Vascular | ||||||
| 09/13/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.95 | General |
| Category: Cardiovascular | ||||||
| 08/17/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $117.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $28.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/07/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.81 | General |
| Category: Cardiovascular | ||||||
| 06/27/2023 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $86.58 | General |
| Category: Vascular | ||||||
| 06/14/2023 | ShockWave Medical, Inc | SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) | Food and Beverage | In-kind items and services | $190.32 | General |
| Category: Lithoplasty | ||||||
| 06/14/2023 | Boston Scientific Corporation | Interlock (Device) | Food and Beverage | In-kind items and services | $163.72 | General |
| Category: Interlock_PI | ||||||
| 05/24/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.70 | General |
| Category: Cardiovascular | ||||||
| 05/18/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $161.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 656 | 842 | $614,883 | $122,310 |
| 2022 | 10 | 656 | 853 | $566,980 | $116,723 |
| 2021 | 11 | 803 | 1,027 | $739,640 | $146,864 |
| 2020 | 15 | 768 | 984 | $721,145 | $148,326 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 48 | 59 | $154,773 | $32,347 | 20.9% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 87 | 88 | $116,160 | $21,912 | 18.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 86 | 148 | $60,680 | $17,466 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 90 | 94 | $75,200 | $15,998 | 21.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 36 | 58 | $72,500 | $12,190 | 16.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 59 | 90 | $27,000 | $6,855 | 25.4% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 28 | 28 | $30,240 | $5,792 | 19.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 44 | 53 | $22,260 | $4,713 | 21.2% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 42 | 43 | $18,060 | $2,915 | 16.1% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 136 | 181 | $38,010 | $2,122 | 5.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 84 | 86 | $113,520 | $23,118 | 20.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 126 | 218 | $89,380 | $21,662 | 24.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 103 | 109 | $87,200 | $20,651 | 23.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 31 | 34 | $88,740 | $20,130 | 22.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 50 | $62,500 | $9,994 | 16.0% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 32 | 33 | $35,640 | $7,225 | 20.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 90 | $27,000 | $6,173 | 22.9% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2022 | 37 | 43 | $18,060 | $4,024 | 22.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 131 | 166 | $34,860 | $2,043 | 5.9% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2022 | 23 | 24 | $10,080 | $1,704 | 16.9% |
| 92928 | Catheter placement of stents in major coronary artery or branch, accessed through the skin, each additional artery or branch | Facility | 2021 | 49 | 58 | $151,380 | $34,175 | 22.6% |
| 93458 | Insertion of catheter in left heart for imaging of blood vessels and left lower heart including imaging interpretation and supervision and injection | Facility | 2021 | 108 | 108 | $142,560 | $28,897 | 20.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 123 | 247 | $102,110 | $23,491 | 23.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 65 | 92 | $115,000 | $18,095 | 15.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 89 | 93 | $74,400 | $17,298 | 23.3% |
About Dr. John Fox, MD
Dr. John Fox, MD is a Cardiovascular Disease healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861476954.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Fox, MD has received a total of $6,641 in payments from pharmaceutical and medical device companies, with $374.67 received in 2024. These payments were reported across 128 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,602).
As a Medicare-enrolled provider, Fox has provided services to 2,883 Medicare beneficiaries, totaling 3,706 services with total Medicare billing of $534,224. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location New York, NY
- Active Since 12/01/2005
- Last Updated 01/15/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1861476954
Products in Payments
- Alto Abdominal Stent Graft System (Device) $856.85
- DRAGONFLY OPSTAR (Device) $563.85
- ELIQUIS (Drug) $521.62
- XARELTO (Drug) $426.90
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $219.77
- ENTRESTO (Drug) $215.89
- CoreValve Evolut (Device) $212.60
- Impella (Device) $202.83
- HawkOne (Device) $194.10
- Lumason (Drug) $191.81
- CARDIOMEMS (Device) $191.01
- Xience Sierra Coronary Stent (Device) $173.16
- CardioMEMS HF System (Device) $170.35
- COREVALVE EVOLUT R (Device) $165.15
- Interlock (Device) $163.72
- MITRACLIP (Device) $148.75
- BOTOX - NEUROLOGY (Drug) $146.52
- LUTONIX Drug Coated Balloon (Device) $140.37
- CAMZYOS (Drug) $129.30
- Mitra Clip system (Device) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New York
Dr. Roger Hajjar, Md, MD
Cardiovascular Disease — Payments: $5.2M
Dr. Jacob Koruth, M.d, M.D
Cardiovascular Disease — Payments: $3.2M
Dr. Martin Leon, M.d, M.D
Cardiovascular Disease — Payments: $2.7M
Dr. Gregg Stone, M.d, M.D
Cardiovascular Disease — Payments: $2.2M
Adam Rosenbluth, Md, MD
Cardiovascular Disease — Payments: $1.5M
Dr. Deepak Bhatt, Md, MD
Cardiovascular Disease — Payments: $1.4M